APPENDIX C: SPEAKER, MODERATOR, AND PLANNING COMMITTEE BIOGRAPHICAL SKETCHES

Margarita Alegría, Ph.D., is the chief of the Disparities Research Unit at the Massachusetts General Hospital and a professor in the Departments of Medicine and Psychiatry (since 2004) at Harvard Medical School. She was the director of the Center for Multicultural Mental Health Research at Cambridge Health Alliance (2002–2015) and director of the Center for Evaluation and Sociomedical Research at the University of Puerto Rico. She has remained dedicated to generating knowledge that can be used to increase equity in health outcomes and health care services for disadvantaged and minority populations. Dr. Alegría’s research has integrated three methods: a multidisciplinary and multisectorial approach; a multilevel framework that gives necessary consideration to environmental and social contexts and the individual and family system; and a strong focus on which aspects of culture and context need to be addressed to improve health, as well as service delivery for diverse populations.

Dr. Alegría is the principal investigator (PI) of three National Institutes of Health (NIH)-funded research studies: Building Community Capacity for Disability Prevention in Minority Elders; Mechanisms Underlying Racial/Ethnic Disparities in Mental Disorders; and The Impact of Medicaid Plans on Access to and Quality of Substance Use Disorder (SUD) Treatment. She is also the PI of a grant funded by the William T. Grant Foundation, Using the Experience of Majority and Minority Status Through Photovoice. Dr. Alegría has published more than 200 papers, editorials, and intervention training manuals and several book chapters on topics such as improvement of health care services delivery for diverse racial and ethnic populations, conceptual and methodological issues with multicultural populations, and ways to bring the community’s perspective into the design and implementation of health services.

In October 2011, she was elected as a member of the National Academy of Medicine (NAM) in acknowledgement of her scientific contributions to her field. She has also received notable awards, such as the Mental Health Section Award by the American Public Health Association (2003), Health Disparities Innovation Award by the National Institute on Minority Health and Health Disparities (2008), Simone Bolivar Award by the American Psychiatry Association (2009), and Jonathan Mann Award by the New Mexico Public Health Association in recognition of her lifetime commitment to public health and social justice issues (2018). Dr. Alegría obtained her B.A. in psychology from Georgetown University in 1978 and her Ph.D. from Temple University in 1989.

Deidre M. Anglin, Ph.D., is an associate professor of psychology in the doctoral clinical psychology program at the City College of the City University of New York with postdoctoral research training in psychiatric epidemiology at Columbia University’s Mailman School of Public Health. Dr. Anglin leads several projects and mentors students in her Clinical and Social Epidemiology (CASE) Lab designed to identify social determinants of psychosis risk in racial and ethnic minoritized populations. She has published papers focused on race, racism, and psychosis and the stigma of mental health service use in Black and Asian populations. She is the lead investigator of three federally funded studies, one examining anti-Black racism and neighborhood factors among Black young people with a first episode of psychosis. She is one of the First 100 doctoral scholars in the Leadership Alliance and a member of NIH’s National Research Mentoring Network (NRMN).

Melinda Baldwin, Ph.D., LCSW, is the director of the Division of Prevention, Traumatic Stress, & Special Programs and acting chief of the Child, Adolescent, & Family Branch in the Center for Mental Health Services at the Substance Abuse and Mental Health Services Administration (SAMHSA). Dr. Baldwin is a subject matter expert in behavioral health, trauma, program evaluation (grounded in implementation science), and its intersection with child welfare/maltreatment and mental health practice and policy. Before SAMHSA, she was at the Children’s Bureau, leading its work in behavioral health and trauma; she partnered with Office of the Assistant Secretary for Planning and Evaluation, Centers for Disease Control and Prevention, and Centers for Medicare & Medicaid Services, to conduct research on children and youth in congregate care, the intersection of behavioral health care, fetal alcohol syndrome disorder, congregate care, and the impact of substance use on child welfare. She has extensive field experience, beginning on the front lines as a social worker with families in the child welfare system. She was the director of Child Welfare at Hephzibah Children’s Association managing the service continuum to children and their families from community prevention to therapeutic residential services. Dr. Baldwin has a Ph.D. in social work from the University of Illinois—Chicago and an M.S.W. from the University of Illinois—Urbana-Champaign and is licensed as a clinical social worker in both Illinois and in the District of Columbia.

Deanna Barch, Ph.D., studies cognitive and language deficits in disorders such as schizophrenia and the neurobiological mechanisms that contribute to such deficits. Her research includes behavioral, pharmacological, and neuroimaging studies with typical and clinical populations. Dr. Barch’s research is focused on understanding the interplay among cognition, emo-

tion, and brain function to better understand the deficits in behavior and cognition found in illnesses such as schizophrenia and depression. In particular, she is interested in determining the cognitive, emotional, and neural bases of risk for the development of schizophrenia and depression, potentially to inspire better preventative approaches. She uses functional magnetic resonance imaging (MRI), structural MRI, and cognitive neuroscience methods to examine neural basis of disturbances in cognitive control and emotional processing in individuals living with or at risk of developing schizophrenia and individuals with mood disorders. Furthermore, her work includes a focus on the ways in which early adversity (e.g., poverty, stress, and disparities in access to health care) shape early brain development and risk for mental health challenges.

Lisa Dixon, M.D., M.P.H., is the Edna L. Edison Professor of Psychiatry at the Columbia University Vagelos College of Physicians and Surgeons and New York-Presbyterian Hospital. She directs the Division of Behavioral Health Services and Policy Research within the Department of Psychiatry. Dr. Dixon is an internationally recognized health services researcher with more than 25 years of continuous funding from the National Institute of Mental Health (NIMH) and the U.S. Department of Veterans Affairs. She oversees activities for the New York State Office of Mental Health in implementing evidence-based practices for persons diagnosed with serious mental illness. Dr. Dixon’s grants have focused on improving the quality of care for individuals with serious mental disorders. Her work has joined individuals engaged in self-help and outpatient psychiatric care, clinicians, and policy makers in collaborative research endeavors. Dr. Dixon assumed the role of editor-in-chief of Psychiatric Services in January 2017. She has published more than 350 articles in peer-reviewed journals and received numerous awards, including the 2009 American Psychiatric Association Health Services Senior Scholar Award and Wayne Fenton Award for Exceptional Clinical Care. In 2016, the Mental Health Section of the American Public Health Association recognized her work with the Carl A. Taube Award. She is a member of the board of directors for the National Alliance on Mental Illness (NAMI).

Sabrina Ereshefsky, Ph.D., is a license-eligible clinical psychologist postdoctoral scholar in the Department of Psychiatry and Behavioral Sciences at University of California—Davis (UCD). She provides training, supervision, and assessment services as part of UCD’s SacEDAPT, a coordinated specialty care clinic serving low-income clients and families. Dr. Ereshefsky joined Early Psychosis Intervention Network’s California Hub, working with PI Dr. Tara Niendam on the “California Collaborative Network to Promote Data-Driven Care and Improve Outcomes in Early Psychosis (EPI-CAL).”

Her work focuses on understanding clinician- and organization-level characteristics that may impact implementation and uptake of Beehive, the data collection and visualization platform to improve data-driven care. Dr. Ereshefsky collaborated with the SCOPING Review workgroup, under the leadership of Drs. Deidre Anglin and Els van der Ven, to develop a narrative review and meta-analysis regarding the relationship between social determinants of health and psychosis. Last April, they published “From Womb to Neighborhood: A Racial Analysis of Social Determinants of Psychosis in the United States” in the American Journal of Psychiatry. Dr. Ereshefsky led the trauma review. She received her Ph.D. in human services psychology with a concentration in child clinical psychology from the University of Maryland—Baltimore County and completed her predoctoral clinical internship at University of Arizona’s Early Psychosis Intervention Center.

Anita S. Everett, M.D., DFAPA, is the director of the Center for Mental Health Services in the Substance Abuse and Mental Health Services Administration. She oversees the administration of grants and programs that aim to increase access to quality treatment for persons with or at risk for mental illnesses. Dr. Everett has experience in delivering and leading psychiatric services. Earlier, she was at the Johns Hopkins school of medicine and Bloomberg School of Public Health, where she led a full range of outpatient and intensive community services in east Baltimore. Dr. Everett is a past president of the American Psychiatric Association and American Association of Community Psychiatry and received commendation for her work in national health care reform and advocacy.

Mary Giliberti, J.D., is chief public policy officer for Mental Health America, the leading community-based nonprofit dedicated to addressing the needs of those living with mental illness and promoting the overall mental health of all Americans. She focuses on federal policy to promote prevention, early intervention, and recovery. She spent 5 years as the chief executive officer of NAMI. During her 20+ years in the mental health field, she also served as disability counsel for the Senate Committee on Health, Education, Labor and Pensions and as a senior attorney at the Bazelon Center for Mental Health Law.

Howard Goldman, M.D., Ph.D., is a professor of psychiatry at the University of Maryland, School of Medicine. His expertise is in evaluating mental health services and financing programs and policies. Dr. Goldman’s recent research has focused on evaluating employment demonstrations for people with severe mental disorders who are connected to the disability programs of the Social Security Administration (SSA). He has also been involved in studies related to early intervention services for individuals experiencing

a first episode of psychosis. He served as PI of the study team conducting the Evaluation of the Implementation and Impact of Mental Health and Substance Abuse Parity in the Federal Employees Health Benefits program, sponsored by the government.

Dr. Goldman served as the senior scientific editor of the Surgeon General’s Report on Mental Health from 1997 to 1999, for which he was awarded the Surgeon General’s Medallion. During 2002 and 2003, Dr. Goldman was a consultant to the president’s New Freedom Commission on Mental Health. From 2004 to 2016, he was editor of Psychiatric Services, a mental health services research and policy journal published monthly by the American Psychiatric Association. He has been on the editorial boards of several other journals, including Health Affairs, American Journal of Psychiatry, and Journal of Mental Health Policy and Economics. He is a member of the National Academy of Social Insurance, having served on its disability policy panel.

Dr. Goldman is an NAM member and chairs a standing committee advising SSA on its disability programs. He has also served as a member or consultant on numerous National Academies consensus committees related to disability policy. Dr. Goldman received a joint M.D.-M.P.H. from Harvard University and a Ph.D. in social policy research from the Heller School at Brandeis University.

Robert Heinssen, Ph.D., ABPP, is director of the Division of Services and Intervention Research at NIMH. He is recognized internationally as a leader in science-to-practice initiatives in serious mental illness, including translational research in psychosis risk states, comparative effectiveness and implementation trials in first-episode psychosis, and suicide prevention in military and civilian settings. His research and public policy contributions have facilitated rapid and substantial growth of science-based early-intervention services nationwide. He is the principal architect of the nation’s first learning health care system for persons with serious mental illness, the Early Psychosis Intervention Network (EPINET). Dr. Heinssen has received many national and international awards for his visionary leadership in creating, implementing, and sustaining science-guided, person-centered treatment programs for serious mental illness. These include the Angelo Cocchi Award from the International Early Psychosis Association; Andrew C. Leon Distinguished Career Award from the International Society for Central Nervous System Clinical Trials and Methodology; Hubert Humphrey Award for Service to America from the U.S. Department of Health and Human Services; Distinguished Service Award from National Alliance on Mental Illness; Valiant Researcher Award from the Schizophrenia and Related Disorders Alliance of America; and Special Presidential Commendation from the American Psychiatric Association. Dr. Heinssen serves as

NIMH liaison to the International Initiative for Mental Health Leadership, the Substance Abuse and Mental Health Services Administration, the Patient-Centered Outcomes Research Institute (PCORI), and Department of Veterans Affairs Center for Compassionate Innovation Advisory Council. He is a board-certified, licensed, and practicing clinical psychologist, fellow of the American Academy of Clinical Psychology, and veteran of the U.S. Army Medical Services Corps.

Nev Jones, Ph.D., is an assistant professor of social work at the University of Pittsburgh and affiliated faculty in the Department of Psychiatry. An alumna of early intervention in psychosis services, she has been actively involved in U.S. CSC development and research for the past decade. Areas of focus including addressing social and structural determinants of disability/recovery and improving long-term outcomes both generally and specifically for individuals initially enrolled in CSC. She has also championed the involvement and leadership of individuals with direct experience of psychosis/schizophrenia nationally and internationally and leads the lived experience and participatory methods work package for the Lancet Psychiatry Commission on the Psychoses.

John M. Kane, M.D., is the senior vice president for Behavioral Health Services at Northwell Health in New Hyde Park, New York, chair of the Department of Psychiatry at the Zucker Hillside Hospital in Glen Oaks, New York, and professor and chair of psychiatry at the Donald and Barbara Zucker school of medicine at Hofstra/Northwell. Dr. Kane is the recipient of many awards, including the Lieber Prize, American Psychiatric Association’s Kempf Award and Foundations Prize, New York State Office of Mental Health Lifetime Achievement Award, and Dean Award from the American College of Psychiatrists. He was president of the American Society of Clinical Psychopharmacology, Psychiatry Research Society, and Schizophrenia International Research Society. Dr. Kane has been the PI for research projects focusing on schizophrenia, psychobiology and treatment, recovery, and improving the quality and cost of care. He is the author of more than 800 peer-reviewed papers and on the editorial boards of numerous journals. He earned his medical degree from New York University, completed his internship and residency in psychiatry at the Zucker Hillside Hospital, and is a diplomate of the American Board of Psychiatry and Neurology.

Ted Lutterman is senior director of government and commercial research at the National Association of State Mental Health Program Directors (NASMHPD) National Research Institute (NRI). He has more than 20 years of experience working directly with state mental health authorities

developing, compiling, analyzing, and using performance measures and data on mental health services, finances, and outcomes. He leads NRI’s State Profiling System, State Data Infrastructure Coordinating Center, and Olmstead Data Pilot.

Patrick McGorry, M.D., Ph.D., FRCP, FRANZCP, FAA, FASSA, FAHMS, is an Irish-born, Australian psychiatrist known worldwide for his development and scaling up of early intervention and youth mental health services and for mental health innovation, advocacy, and reform. He is executive director of Orygen, professor of Youth Mental Health at the University of Melbourne, and founding editor of Early Intervention in Psychiatry. He led the advocacy that resulted in the Australian government establishing the National Youth Mental Health Foundation in 2005 (in 2006, it became Headspace) and remains a founding board member. Dr. McGorry has more than 980 publications with 47,266 citations and an h-index of 112 (Scopus). He has played a key advocacy and advisory role to government and health system reform in Australia and many parts of the world. He is president of the International Association for Youth Mental Health, past president of the Schizophrenia International Research Society and the Society for Mental Health Research, and was founding president and is now treasurer of the IEPA: Early Intervention in Mental Health. He is also a founding board member of Australians for Mental Health.

In 2010, Dr. McGorry was selected as Australian of the Year and became an Officer of the Order of Australia. In 2013, he received the Annual Research Award from the NAMI in Washington, DC; in 2015, he was awarded the Lieber Prize for Schizophrenia Research by the U.S.-based Brain and Behavior Foundation; in 2016, he became the first psychiatrist to be elected as a Fellow of the Australian Academy of Science; in 2018, he received the Schizophrenia International Research Society Lifetime Achievement Award; and in 2019, he earned the Humanitarian Award of the Society of Biological Psychiatry and National Health and Medical Research Council Research Excellence Award. In 2019–2020, he was chair of the Expert Advisory Committee, Royal Commission into Victoria’s Mental Health System. Other roles include president and member of the Committee of Management of the Celtic Club, a national patron of the Justice Reform Initiative, Member of the National Committee of the Australian Republican Movement, and board member of Ausflag.

Theresa Nguyen, M.S.W., is Mental Health of America (MHA)’s chief program officer and manages MHA’s programs, including MHA Screening, the State of Mental Health in America, and Workplace Wellness. MHA Screening (www.mhascreening.org) is a confidential and anonymous platform with more than 13 million screens since it began 7 years ago and more

than 5 million in 2021 alone. Her clinical experience focused on working with children and adults in community mental health, homelessness, dual diagnosis treatment, and early intervention of psychosis. As a mental health advocate, she worked to build a consumer-based workforce, improve access to treatment through community-based and recovery-oriented programs, and address needs of underserved communities. She teaches at University of California—Irvine’s Advanced Immigrant Rights Clinic and California State University—Fullerton’s Department of Social Work. She is a board member of Project Return Peer Support Network, member of the U.S. Olympic & Paralympic Committee Mental Health Taskforce and Mental Health Research Network Advisory Committee, and PCORI ambassador.

Tara Niendam, Ph.D., is an associate professor and vice chair of research in the Department of Psychiatry and Behavioral Science at UCD. She is the executive director of the UCD early-psychosis programs (Early Diagnosis and Preventative Treatment [EDAPT] and SacEDAPT Clinics) and has developed four programs in Northern California based on the CSC model. Her research focuses on improving clinical and functional outcomes for youth with serious mental illness, with a focus on mobile health technology. Her work examines multiple predictors of outcome, including cognition, neuroimaging, trauma and social determinants, and prevention of negative outcomes, such as suicide and homelessness. She is the PI for EPI-CAL, part of EPINET. EPI-CAL links multiple county- and university-based early psychosis programs to bring client-level data to the clinician’s fingertips and enable large-scale data-driven approaches to improve outcomes for EP care. She also directs the EPI-CAL-affiliated Training and Technical Assistance Center, which seeks to bring evidence-based early-psychosis care to all Californians. She completed her Ph.D. in clinical psychology at the University of California—Los Angeles.

Oladunni Oluwoye, Ph.D., is an assistant professor in the Elson S. Floyd College of Medicine at Washington State University—Spokane and the co-director of the Washington State Center of Excellence in Early Psychosis. She is a health services researcher who uses cultural- and community-informed approaches to address inequities in mental health care. Dr. Oluwoye also serves as the lead evaluator for New Journeys, a network of CSC programs in Washington State. Much of her research is supported by grants from NIMH focused on the development and implementation of strategies to increase engagement and service use in CSC and other services among racially and ethnically diverse families.

Dost Öngür, M.D., Ph.D., is a native of Istanbul, Turkey, and the chief of the Psychotic Disorders Division at McLean Hospital, responsible for all clinical services for patients with psychotic disorders. He is also the William P. and Henry B. Test Professor of Psychiatry at Harvard Medical School. His research uses neuroimaging to probe brain abnormalities in psychotic disorders and clinical studies to understand the trajectories of illness in early phases of these disorders. He is the author of more than 200 articles on research into neurobiology and psychosis and the PI of a P50 Center grant from NIMH focused on early-psychosis research. He has won awards from McLean, Harvard Medical School, and American Psychiatric Association (the Kempf Award) for his teaching and mentoring. He is the editor-in-chief of JAMA Psychiatry, a premier journal in the field. He is incoming president of the American Psychopathological Association, Councilor-at-Large for the Society of Biological Psychiatry, and a member of the Brain & Behavior Research Foundation/National Alliance Research on Schizophrenia & Depression Scientific Council. Dr. Öngür obtained his M.D./Ph.D. from Washington University with a Ph.D. in neurobiology. He completed his psychiatric residency training at the MGH/McLean Adult Psychiatry program and stayed on as faculty at McLean/Harvard.

Carol Ott, PharmD, BCPP, is a clinical professor of pharmacy practice at the Purdue University College of Pharmacy and adjunct faculty at the Indiana University (IU) School of Medicine (IUSM). She teaches psychiatric and neurologic pharmacotherapy at Purdue and didactics in psychopharmacology in the IU psychiatry residency program. She is a clinical pharmacy specialist in outpatient psychiatry and gender health at Eskenazi Health, working under collaborative practice agreements in the Prevention and Recovery Center for Early Psychosis (PARC) and Gender Health programs to provide medication management and monitoring. At Purdue, Dr. Ott is the mental health and gender health faculty lead for the Center for Health Equity and Innovation in the College of Pharmacy and faculty lead of BoilerWoRx, a multidisciplinary public health outreach program that partners pharmacy and medicine faculty with Purdue students in pharmacy, nursing, and engineering and IUSM—West Lafayette students to provide educational outreach to community members and health workers along with the Tippecanoe County Health Department.

Dr. Ott is a member of the Indiana Medicaid Drug Utilization Review Board, Psychotropic Medication Advisory Committee, and Mental Health Quality Advisory Committee and an expert panelist for Project ECHO for Opioid Use Disorders through IUSM and the LGBTQIA+ ECHO through IU Fairbanks School of Public Health. She was a secretary of the board of directors for the College of Psychiatric and Neurologic Pharmacists (CPNP) and past member of the CPNP Foundation Board. Dr. Ott is an editor for

the CPNP Psychiatric Pharmacotherapy Review Course for Board Certification in Psychiatric Pharmacy. Dr. Ott is the president of the board of directors for NAMI West Central Indiana. Her areas of research include medication use in first-episode schizophrenia and mental health in transgender individuals.

Kathy Pham, Pharm.D., BCPPS, is the director of policy and professional affairs at the American College of Clinical Pharmacy (ACCP), a professional and scientific society that provides leadership, education, advocacy, and resources enabling clinical pharmacists to achieve excellence in practice, research, and education. She was the senior officer of the Drug Safety Project for the Pew Charitable Trusts. Her clinical experience has been in pediatric pharmacy practice, mostly as the NICU clinical specialist and pharmacy residency director at Children’s National Medical Center in Washington, D.C. She is also a board-certified pediatric pharmacotherapy specialist.

Dr. Pham leads ACCP’s engagement, collaboration, and communication with medical, pharmacy, other health professional societies, health quality organizations, and payers/purchasers to promote and help achieve medication optimization for individual patients and populations. She participates as the ACCP representative in working groups and task forces of health policy development and research enterprises at the national level that address issues of interprofessional practice, research, and education. Dr. Pham earned her Doctor of Pharmacy from Rutgers, the state university of New Jersey. After completing her pharmacy residency at the University of Illinois—Chicago, she practiced as a pediatric clinical pharmacist and held faculty appointments at various schools of pharmacy, including Long Island University, Rutgers, Creighton University, University of Maryland, and Virginia Commonwealth University.

Ruth Shim, M.D., M.P.H., is the associate dean of diverse and inclusive education for the Luke & Grace Kim Professorship in Cultural Psychiatry in the Department of Psychiatry and Behavioral Sciences at the UCD School of Medicine. She is a professor of clinical psychiatry, director of cultural psychiatry, and chair of the Vice Chancellor’s Advisory Committee on Faculty Excellence in Diversity at UC Davis Health. She is a member of the board of trustees of the Robert Wood Johnson Foundation and the American Association of Community Psychiatrists. She is on the editorial boards of Psychiatric Services, Community Mental Health Journal, and American Psychiatric Publishing and coeditor of the book The Social Determinants of Mental Health. She is a 2018–2019 Fellow of the Executive Leadership

in Academic Medicine (ELAM) Program. Dr. Shim’s research focuses on mental health disparities and inequities, and she provides clinical psychiatric care in the UCD EDAPT Clinic. She received an M.P.H. in health policy from Rollins School of Public Health at Emory University and an M.D. from Emory University School of Medicine.

Kristina West, M.S., LLM, leads Office of the Assistant Secretary for Planning and Evaluation’s work on maternal and child behavioral health. She chairs a U.S. Department of Health and Human Services workgroup on Neonatal Abstinence Syndrome and prenatal substance exposures and serves as an expert on substance use records confidentiality (i.e., Part 2 privacy). She also focuses on children and adolescents with mental health needs (including young adults with early psychosis) and school mental health (including telehealth). She joined the Behavioral Health Policy Division as a Presidential Management Fellow in 2014. Earlier, she was an analyst at the George Washington University Department of Health Policy, where she managed research projects on Medicaid managed care, maternal health, Early Psychosis Intervention Network, and coordinated care models for children with complex mental health and physical conditions. She started her career in human rights monitoring and global health. She has a joint B.A./LLM from the University of National and World Economy in Sofia, Bulgaria, and an M.S. in health policy from George Washington University.

This page intentionally left blank.